香港股市 已收市

Evolent Health, Inc. (EVH)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
28.32-0.94 (-3.21%)
收市:04:00PM EDT
29.42 +1.10 (+3.88%)
收市後: 05:50PM EDT

Evolent Health, Inc.

1812 N. Moore Street
Suite 1705
Arlington, VA 22209
United States
571 389 6000
https://www.evolent.com

版塊Healthcare
行業Health Information Services
全職員工4,700

高階主管

名稱頭銜支付行使價出生年份
Mr. Seth Barrie BlackleyCo-Founder, CEO & Director1.79M941.25k1979
Mr. Dan McCarthyCEO of New Century Health & President1.29M1985
Mr. John Paul JohnsonChief Financial Officer994.22k1984
Mr. Jonathan David Weinberg J.D.Chief Legal Officer, General Counsel & Secretary696.07k182.96k1968
Ms. Emily RaffertyChief Operating Officer1983
Mr. Aammaad ShamsChief Accounting Officer341.78k1984
Mr. Robert CruzChief Technology Officer
Ms. Jessica WhiteChief Information Officer
Mr. Seth R. FrankVice President of Investor Relations
Ms. Kali BeyahChief People & Brand Officer
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

公司管治

截至 2024年4月1日 止,Evolent Health, Inc. 的 ISS 管治質素評分為 1。 Pillar 分數正在審核中:6;董事會:1;股東權利:1;現金賠償:2。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。